Skip to content

Effectiveness and Safety of Electro-acupuncture for the Patients with Gastroesophageal Reflux Disease

Effectiveness and Safety of Electro-acupuncture for the Patients with Gastroesophageal Reflux Disease: A Randomized, Patient and Assessor-blinded, Sham-controlled Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001653
Enrollment
60
Registered
2015-10-12
Start date
2015-09-25
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(acupuncture) : ? Electroacupunture group(Treatment group) (1) Using a Park sham device with real needle and electrical stimulation (2) Acupoints (18-20 points) - Comnom points: ST36, a point 0.
2) ‘Spleen-stomach weakness’ type: CV12(one point), ST41 (Rt. side)
3) ‘Spleen-stomach dampness-heat’ type: LR13, SP3 (Rt. side)
4) ‘Stomach yin deficiency’ type: CV12 (one point), ST44 (Rt. side) (3) Duration of treatment sessions: 20 minutes (4) Frequency of treatment sessions: 2/6 Hz (5) Number of treatment sessions: Twice w

Sponsors

Kyung Hee University Oriental Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) are aged between 19 and 75 years (2) are diagnosed with GERD (including both erosive reflux disease and non-erosive reflux disease) within a year (3) have one or more of following symptoms for a month recently : heartburn, regurgitation, dyspepsia, epigastric pain, belching, nausea, globus (feeling of a lump in the esophagus), dysphagia, cough, hoarseness (4) have symptoms stated above either with frequency for =4 days of mild symptom or = 2 days of moderate to severe symptom during last 7 days (mild: symptoms were easily tolerated, the discomfort was only minimal and did not affect normal activities; moderate: symptoms were sufficient to affect normal activities; severe: symptoms markedly affected normal activities) [25] (5) have symptoms stated above despite the experience of standard treatment (pharmacological treatment or lifestyle modification) for GERD during 4 weeks within last one year. (6) agree with participation in this study and sign a written informed consent voluntarily

Exclusion criteria

Exclusion criteria: (1) have structural disease, confirmed by esophagogastroduodenoscopy, related current symptoms (ex. gastrointestinal cancer, eosinophilic esophagitis, candida esophagitis, etc.). (2) have alarm symptoms (severe dysphagia, hematemesis, weight loss, and hematochezia) (3) have past history of gastrointestinal cancer within 5 years (4) have received chemotherapy due to cancer within a month (5) are diagnosed with ischemic heart disease (ex. angina pectoris, myocardial infarction) (6) have artificial cardiac pacemaker in the chest (7) experienced hypersensitivity reaction after acupuncture treatment or are not feasible person to take the acupuncture treatment (8) are taking part in the other clinical trial which might affect the result of this trial or taking Korean medical treatment related GERD; minimum wash-out period of two weeks is required before participating in the trial (9) Individuals who have difficulties in attending the trial (e.g serious mental illness, dementia, drug addiction, severe disorder in vision or hearing, illiteracy, and time constraint etc.) (10) are pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frame
proportion of responders (PR)

Secondary

MeasureTime frame
Nepean Dyspepsia Index - Korean version (NDI-K);gastrointestinal hormone(Gastrin, Motilin);Inflammatory mediator cytokine (IL-1, IL-6, IL-8, IL-4, and IL-10 );EuroQol-5 Dimension (EQ-5D);Korean Gastrointestinal Symptom rating scale (KGSRS) ;11 point Numerical Rating Scale (NRS);Perceived Stress Scale (PSS);Blinding Index & Credibility assessment ;Pattern Identification for Gastroesophageal Reflux Disease (PIGERD);The Acupuncture Beliefs Scale;Patient Global Impression of Change (PGIC);Qi-stagnation questionnaire;Spleen Qi Deficiency Questionnaire;Evaluation of rescue medicine;adverse events

Countries

Korea, Republic of

Contacts

Public ContactGajin Han

Kyung Hee University

kmdhgj@naver.com+82-2-958-9735

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 1, 2026